| Annual Financials | 2015 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
Revenue  | 0 | 2,408 | 2,363 | 2,398 | 2,479 | 3,000 | 3,046 | 3,614 | 3,925 | 3,959 | 4,258 | 3,412 | 4,390 |
| Expenses | 0 | 1,849 | 1,670 | 1,656 | 1,840 | 2,338 | 2,398 | 2,690 | 3,071 | 3,049 | 3,235 | 2,503 | 3,178 |
| EBITDA | 0 | 559 | 693 | 742 | 640 | 663 | 648 | 924 | 854 | 909 | 1,023 | 908 | 1,212 |
| Operating Profit % | 0 % | 21 % | 27 % | 29 % | 25 % | 21 % | 20 % | 25 % | 21 % | 22 % | 23 % | 26 % | 26 % |
| Depreciation | 0 | 53 | 52 | 60 | 52 | 50 | 48 | 48 | 53 | 58 | 57 | 32 | 38 |
| Interest | 0 | 6 | 6 | 10 | 5 | 6 | 6 | 6 | 11 | 11 | 27 | 14 | 12 |
| Profit Before Tax | 0 | 501 | 636 | 672 | 582 | 607 | 594 | 870 | 790 | 840 | 939 | 862 | 1,161 |
| Tax | 0 | 155 | 213 | 239 | 207 | 188 | 161 | 218 | 214 | 161 | 264 | 226 | 303 |
| Net Profit | 0 | 346 | 423 | 433 | 375 | 419 | 433 | 652 | 576 | 678 | 675 | 637 | 860 |
| EPS in ₹ | 0.00 | 106.63 | 130.16 | 133.31 | 115.40 | 129.12 | 133.42 | 200.79 | 177.37 | 208.91 | 207.95 | 196.11 | 264.80 |
P&G Hygiene and Health Care
P&G Hygiene and Health Care
11,787.00
-134.00
(-1.12%)
Market Cap
38,261.47 Cr
PE Ratio
45.05
Volume
5,177.00
Day High - Low
12,000.00 - 11,701.00
52W High-Low
14,800.00 - 11,612.00
Q3 Quarterly Results are out. Check out the updated financials1 day ago
View
Key Fundamentals
Market Cap
38,261.47 Cr
EPS
196.11
PE Ratio
45.05
PB Ratio
41.58
Book Value
286.89
EBITDA
908.40
Dividend Yield
1.47 %
Industry
Consumer Goods Sector
Personal Care Return on Equity
86.38
Debt to Equity
0.00
Analyst Rating and Forecast
- By Refinitiv from3 analysts
Actual
Company News
View All News
P&G Hygiene and Health Care reports strong Q3FY26 performance with net profit rising 12.2% YoY to ₹301.46 crore. Board declares interim dividend of ₹195 per share including special dividend.
Procter & Gamble Hygiene and Health Care Limited has scheduled a board meeting on January 30, 2026, to consider declaration of interim dividend for FY2025-26, as announced in regulatory filing.
Procter & Gamble Hygiene and Health Care Limited Announces Leadership Change in Healthcare DivisionDec 01, 2025
Ms. Maitrheyi Jagannathan will cease to be Category Leader, Health Care at Procter & Gamble Hygiene and Health Care Limited effective December 31, 2025, as she leaves to pursue other interests. Mr. Tushar Gupta, currently Senior Director leading brand design and communication for Vicks and Zzzquil in the APAC region, will take over as Category Leader-Health Care effective January 1, 2026.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,170.10 | #1 1,19,729.85 | 65.30 | #1 14,680.40 | 2.19 | #1 1,852 | -0.08 | 40.41 | |
499.00 | 88,507.14 | 48.95 | 13,113.20 | 1.76 | 1,740 | 7.33 | 40.18 | |
2,127.40 | 57,862.22 | 43.17 | 6,179.00 | 7.33 | 1,437 | 0.34 | 51.05 | |
11,787.00 | #4 38,261.47 | #4 45.05 | #5 3,411.80 | #9 -19.87 | #5 637 | #5 12.25 | 32.18 | |
8,682.00 | 28,290.49 | 45.73 | 2,262.80 | -14.91 | 418 | 36.90 | 62.86 | |
482.45 | 21,058.94 | 27.51 | 3,877.30 | 6.96 | 803 | -29.67 | 37.96 | |
408.30 | 10,961.51 | 131.29 | 203.20 | #1 13.97 | 41 | 195.50 | 48.74 | |
275.45 | 8,962.31 | 68.64 | 2,145.70 | 8.94 | 73 | #1 310.75 | 47.02 | |
348.15 | 4,547.48 | #1 26.07 | 1,000.40 | -2.76 | 125 | 83.40 | 68.63 | |
952.85 | 1,723.38 | 104.94 | 77.10 | - | 16 | - | 70.05 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
-19.87 %
Net Income Growth
-5.69 %
Cash Flow Change
26.21 %
ROE
-0.85 %
ROCE
-6.71 %
EBITDA Margin (Avg.)
10.87 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 1,948 | 1,948 | 2,166 | 1,160 | 1,425 | 1,617 | 1,828 | 1,633 | 1,683 | 2,137 | 1,859 | 1,755 |
| Fixed Assets | 309 | 309 | 317 | 286 | 250 | 234 | 207 | 184 | 164 | 170 | 139 | 131 |
| Current Assets | 1,356 | 1,357 | 1,632 | 603 | 815 | 1,090 | 1,328 | 1,117 | 1,135 | 1,496 | 1,200 | 1,091 |
| Capital Work in Progress | 39 | 39 | 35 | 41 | 22 | 15 | 22 | 38 | 44 | 23 | 28 | 41 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 1,600 | 1,600 | 1,814 | 834 | 1,154 | 1,368 | 1,600 | 1,411 | 1,475 | 1,945 | 1,692 | 1,583 |
| Total Liabilities | 1,948 | 1,948 | 2,166 | 1,160 | 1,425 | 1,617 | 1,828 | 1,633 | 1,683 | 2,137 | 1,859 | 1,755 |
| Current Liabilities | 599 | 716 | 511 | 582 | 571 | 643 | 595 | 836 | 860 | 1,085 | 981 | 901 |
| Non Current Liabilities | 3 | 3 | 4 | 52 | 49 | 66 | 76 | 83 | 85 | 106 | 103 | 117 |
| Total Equity | 1,346 | 1,229 | 1,652 | 526 | 806 | 909 | 1,158 | 714 | 738 | 946 | 775 | 737 |
| Reserve & Surplus | 1,313 | 1,196 | 1,619 | 494 | 773 | 877 | 1,125 | 682 | 705 | 914 | 742 | 705 |
| Share Capital | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 349 | 452 | -964 | 290 | 134 | 358 | -236 | -23 | 339 | -390 | -107 |
| Investing Activities | 28 | 221 | 149 | -20 | 34 | 75 | 7 | -27 | -10 | 1 | -34 |
| Operating Activities | 426 | 353 | 445 | 416 | 413 | 474 | 863 | 573 | 826 | 470 | 593 |
| Financing Activities | -105 | -122 | -1,559 | -106 | -314 | -190 | -1,106 | -569 | -477 | -861 | -666 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 |
| Promoter | 70.64 % | 70.64 % | 70.64 % | 70.64 % | 70.64 % | 70.64 % | 70.64 % | 70.64 % | 70.64 % | 70.64 % | 70.64 % | 70.64 % | 70.64 % | 70.64 % | 70.64 % | 70.64 % | 70.64 % | 70.64 % | 70.64 % | 70.64 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 1.30 % | 1.48 % | 1.57 % | 1.56 % | 1.48 % | 1.43 % | 1.33 % | 1.38 % | 1.11 % | 1.07 % |
| DIIs | 13.30 % | 13.30 % | 13.20 % | 13.19 % | 13.60 % | 13.91 % | 14.37 % | 15.28 % | 15.33 % | 15.43 % | 15.44 % | 15.29 % | 15.11 % | 15.16 % | 15.28 % | 15.37 % | 15.51 % | 15.49 % | 16.06 % | 16.04 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 10.63 % | 10.58 % | 10.57 % | 10.52 % | 10.43 % | 10.37 % | 10.34 % | 10.22 % | 10.15 % | 10.04 % | 9.90 % | 9.88 % | 9.92 % | 9.87 % | 9.80 % | 9.76 % | 9.76 % | 9.74 % | 9.65 % | 9.69 % |
| Others | 5.43 % | 5.48 % | 5.59 % | 5.65 % | 5.32 % | 5.08 % | 4.65 % | 3.87 % | 3.89 % | 3.89 % | 2.72 % | 2.71 % | 2.76 % | 2.77 % | 2.80 % | 2.80 % | 2.76 % | 2.75 % | 2.54 % | 2.57 % |
| No of Share Holders | 39,337 | 39,806 | 41,120 | 40,908 | 40,819 | 41,533 | 43,445 | 40,495 | 39,968 | 39,388 | 37,069 | 38,807 | 39,999 | 40,671 | 42,348 | 42,941 | 44,877 | 47,891 | 49,997 | 50,969 |
Dividend History
| Annual Cash Flows | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 389 | 40 | 88 | 105 | 315 | 160 | 185 | 255 | 175 | 0.00 |
| Dividend Yield (%) | 4.07 | 0.37 | 0.86 | 0.83 | 2.19 | 1.2 | 1.09 | 1.87 | 1.47 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 05 Feb 2026 |  Dividend | ₹ 25.00 /share | 05 Feb 2026 | 11,763.45 | 11,927.50 |
| 05 Feb 2026 | Dividend | ₹ 170.00 /share | 05 Feb 2026 | 11,763.45 | 11,927.50 |
| 11 Feb 2021 | Dividend | ₹ 85.00 /share | 10 Feb 2021 | 11,128.35 | 12,537.60 |
| 12 May 2021 | Dividend | ₹ 150.00 /share | 11 May 2021 | 13,542.15 | 13,691.15 |
| 11 Nov 2021 | Dividend | ₹ 80.00 /share | 09 Nov 2021 | 13,038.55 | 14,440.35 |
| 09 Feb 2022 | Dividend | ₹ 95.00 /share | 08 Feb 2022 | 14,803.60 | 15,222.00 |
| 09 Nov 2022 | Dividend | ₹ 65.00 /share | 04 Nov 2022 | 14,597.50 | 14,082.15 |
| 08 Feb 2023 | Dividend | ₹ 80.00 /share | 08 Feb 2023 | 13,756.20 | 13,647.30 |
| 18 Nov 2023 | Dividend | ₹ 105.00 /share | 17 Nov 2023 | 15,492.15 | 18,427.55 |
| 24 Nov 2023 |  Annual General Meeting | NA | 24 Nov 2023 | 15,492.15 | 17,900.30 |
| 09 Feb 2024 | Dividend | ₹ 60.00 /share | 09 Feb 2024 | 17,165.60 | 16,581.70 |
| 09 Feb 2024 | Dividend | ₹ 100.00 /share | 09 Feb 2024 | 17,165.60 | 16,581.70 |
| 30 Oct 2024 |  Quarterly Result Announcement | NA | 30 Oct 2024 | 16,417.60 | 16,418.55 |
| 20 Nov 2024 | Dividend | ₹ 95.00 /share | 19 Nov 2024 | 17,017.65 | 15,803.50 |
| 26 Nov 2024 | Annual General Meeting | NA | 26 Nov 2024 | 17,017.65 | 15,909.90 |
| 11 Feb 2025 | Quarterly Result Announcement | NA | 11 Feb 2025 | 14,776.50 | 14,101.70 |
| 20 Feb 2025 | Dividend | ₹ 110.00 /share | 20 Feb 2025 | 14,101.70 | 14,004.85 |
| 27 May 2025 | Quarterly Result Announcement | NA | 27 May 2025 | 13,916.05 | 14,234.40 |
| 30 Jul 2025 | Quarterly Result Announcement | NA | 30 Jul 2025 | 13,421.00 | 13,083.65 |
| 28 Aug 2025 | Dividend | ₹ 65.00 /share | 28 Aug 2025 | 14,234.40 | 13,118.00 |
| 04 Sept 2025 | Annual General Meeting | NA | 04 Sept 2025 | 14,232.00 | 13,485.90 |
| 06 Nov 2025 | Quarterly Result Announcement | NA | 06 Nov 2025 | 13,648.00 | 13,410.20 |
| 30 Jan 2026 | Quarterly Result Announcement | NA | 30 Jan 2026 | 13,022.00 | 11,763.45 |
Announcements
Communication In Respect Of Deduction Of Tax At Source (TDS) On The Amount Of Dividend Income From Procter & Gamble Hygiene And Health Care Limited For The FY 2025-26
3 days ago
3 days agoRecord Date For Interim Dividend3 days ago
3 days agoCorporate Action-Board approves Dividend3 days ago
3 days agoAnnouncement under Regulation 30 (LODR)-Press Release / Media Release3 days ago
3 days agoBoard Meeting Outcome for Unaudited Financial Results For The Quarter Ended December 31 2025 And Interim
Dividend For Financial Year 2025-263 days ago
3 days agoUnaudited Financial Results For The Quarter Ended December 31 20253 days ago
3 days agoUpdate on board meetingJan 21, 2026
Jan 21, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 13, 2026
Jan 13, 2026Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter Ended December 31 2025Dec 26, 2025
Dec 26, 2025Closure of Trading WindowDec 26, 2025
Dec 26, 2025Announcement under Regulation 30 (LODR)-Change in ManagementDec 08, 2025
Dec 08, 2025Announcement under Regulation 30 (LODR)-Change in ManagementDec 01, 2025
Dec 01, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 06, 2025
Nov 06, 2025Financial Results For The Quarter Ended September 30 2025Nov 06, 2025
Nov 06, 2025Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended September 30 2025Nov 06, 2025
Nov 06, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 29, 2025
Oct 29, 2025Revision of Board MeetingOct 15, 2025
Oct 15, 2025Closure of Trading WindowSep 29, 2025
Sep 29, 2025Board Meeting Intimation for Intimation Of Board Meeting Scheduled To Be Held On November 6 2025
Sep 29, 2025
Sep 29, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateSep 05, 2025
Sep 05, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateSep 05, 2025
Sep 05, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 05, 2025
Sep 05, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 05, 2025
Sep 05, 2025Reg. 34 (1) Annual Report.Aug 26, 2025
Aug 26, 2025Business Responsibility and Sustainability Reporting (BRSR)Aug 13, 2025
Aug 13, 2025Record Date For Annual General Meeting And DividendAug 13, 2025
Aug 13, 2025Annual General Meeting And Annual Report For The Financial Year 2024-25Aug 13, 2025
Aug 13, 2025Press ReleaseJul 30, 2025
Jul 30, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateJul 30, 2025
Jul 30, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateJul 30, 2025
Jul 30, 2025Board Meeting Outcome for Unaudited Results For The Quarter Ended June 30 2025Jul 30, 2025
Jul 30, 2025Announcement under Regulation 30 (LODR)-Resignation of DirectorJul 23, 2025
Jul 23, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 15, 2025
Jul 15, 2025Closure of Trading WindowJun 27, 2025
Jun 27, 2025Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter Ended June 302025Jun 27, 2025
Jun 27, 2025Change In Senior Management PersonnelJun 23, 2025
Jun 23, 2025Change In Chief Financial Officer Of The CompanyJun 23, 2025
Jun 23, 2025Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)Jun 23, 2025
Jun 23, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJun 12, 2025
Jun 12, 2025Presentation For The Analyst/ Investor MeetJun 12, 2025
Jun 12, 2025Communication In Respect Of Deduction Of Tax At Source (TDS) On The Amount Of Dividend Income From Procter & Gamble Hygiene And Health Care Limited (The Company)Jun 06, 2025
Jun 06, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 29, 2025
May 29, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 28, 2025
May 28, 2025Annual General MeetingMay 28, 2025
May 28, 2025Board Meeting Outcome for Audited Financial Results Dividend And Appointment Of Secretarial AuditorMay 27, 2025
May 27, 2025Change In Communication Details Of The Registrar And Transfer AgentApr 25, 2025
Apr 25, 2025Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 16, 2025
Apr 16, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 16, 2025
Apr 16, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 16, 2025
Apr 16, 2025Board Meeting Intimation for Consideration And Approval Of Audited Financial Results And Statements For The Financial Year Ended March 312025 And To Consider Recommendation Of Dividend If Any.Mar 26, 2025
Mar 26, 2025Mutual Fund Holdings
Technical Indicators
RSI(14)
Neutral 35.28
ATR(14)
Volatile 274.67
STOCH(9,6)
Neutral 25.30
STOCH RSI(14)
Neutral 51.72
MACD(12,26)
Bearish -33.36
ADX(14)
Strong Trend 38.59
UO(9)
Bearish 33.14
ROC(12)
Downtrend And Accelerating -3.73
WillR(14)
Neutral -66.23
About P&G Hygiene and Health Care
Procter & Gamble Hygiene and Health Care Limited (P&GHHCL) is an Indian company that manufactures and sells branded fast-moving consumer goods in the feminine care and healthcare sectors. The company operates in two segments: healthcare products (ointments, creams, cough drops, and tablets) and hygiene products (feminine hygiene and skin care)....more
Website
Chairperson NameChittranjan Dua
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
